Скачать или смотреть Risankizumab for Ulcerative Colitis

Ulcerative colitis can significantly decrease quality of life. A third of patients have persistent symptoms with tumor necrosis factor inhibitors and nearly 1 in 5 patients will be hospitalized within 5 years of diagnosis. Author Gilaad G. Kaplan, MD, MPH, of the University of Calgary joins JAMA Associate Editor John M. Inadomi, MD, to discuss Risankizumab for Ulcerative Colitis.

Related Content:

Monoclonal Antibody Risankizumab for Ulcerative Colitis
https://jamanetwork.com/journals/jama...

Risankizumab for Ulcerative Colitis
https://jamanetwork.com/journals/jama...

Podcast was originally published on July 22, 2024.
https://edhub.ama-assn.org/jn-learnin...

---------------------------------------------------------------------------------
Follow JAMA Author Interviews on:

Youtube:    • JAMA Author Interviews  
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/61HE3v2...
Pocket Casts: https://pca.st/DAh2
Your podcast app of choice: https://pod.link/410339697
Website: https://jamanetwork.com/journals/jama...

---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
•   / jamajournal  
•   / jama_current  
•   / jamanetwork  

Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
•   / jamanetwork  
•   / jamanetwork  
•   / jamanetwork  
•   / jamanetwork